国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
复方法莫替丁咀嚼片治疗胃酸相关性症状的临床观察
The Clinical Effect of Famotidine Co. Chewing Tablet in Treating Gastric Acid Associated Symptoms
投稿时间:2005-08-22  修订日期:2005-10-11
DOI:
中文关键词:  复方法莫替丁咀嚼片 法莫替丁 胃酸 随机双盲对照试验
英文关键词:Gastric acid  Famotidine co. chewing tablets  Famotidine
基金项目:
刘海林  霍立  $2  朱舜时
上海第二医科大学附属第九人民医院,上海200011
摘要点击次数: 1420
全文下载次数: 111
中文摘要:
      目的:评价复方法莫替丁咀嚼片治疗胃酸相关性症状的有效性和安全性。方法:采用随机双盲对照试验,60例患者分别给予复方法莫替丁咀嚼片或法莫替丁片,20mg,bid,疗程14d。结果:两组的总有效率无统计学差异。各临床症状评分在治疗后均有显著下降,但两组间差异无统计学意义。除反酸症状的完全缓解时间,法莫替丁组优于复方法莫替丁咀嚼片组外,其他症状的完全缓解时间,两组间差异无统计学意义。两组均无严重不良反应。结论:复方法莫替丁咀嚼片是治疗胃酸相关性症状安全有效的药物。
英文摘要:
      Objective:To assess efficacy and safety of famotidine co, chewing tablets in treating paitents with sour stomach due to excess stomach acid, Method:A randomized, double-blind,double-modeling,placebo-controlled study was conducted. 60 patients comparing famotidine co. chewing tablets to placebo (famotidine) during a 2-week period. Result: The total effective rates of two groups were similar. The clinic symtom scores were significantly descreased after treatments, but there were no statistic difference. Except the time emission of gastric acid regurgitation, the remission time of other symptoms were no statistic differnenee among two groups. Conclusion: Famotidine co. chewing tablets is safe and effective in treating of patients with gastric acid associated symptoms.
查看全文  查看/发表评论  下载PDF阅读器
关闭